combination therapy

Lilly's oral SERD Ember counts on Verzenio to broaden its glow

Lilly's imlunestrant monotherapy only mounted a PFS benefit in ESR1-mutated tumors, while its pairing with Verzenio moved the needle in a wider group.

Angus Liu Dec 11, 2024 8:15am

business strategy game play plan football soccer

Vir keeps pressure on Gilead with midphase hepatitis D data

Jun 5, 2024 8:52am

spiral failure circle stuck lost missing lose

ASCO: Regeneron misses mark with one CR in solid tumor trial

May 23, 2024 5:00pm

Calliditas' cancer trial misses primary goal, hits on survival

May 7, 2024 6:39am

An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

New immunotherapy drug design ups survival in mice with cancer

Apr 23, 2024 3:40am

Approved IBS drug may help overcome prostate cancer resistance

Jan 22, 2024 11:00am